Abbreviated Screening Protocol for Breast MRI. A Feasibility Study.

Academic Radiology

Volumn 22, Issue 9, 2015, Pages 1157-1162

  Grimm, Lars J ^a   Soo, Mary S ^a   Yoon, Sora ^a   Kim, Connie ^a   Ghate, Sujata V ^a   Johnson, Karen S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Abbreviated protocol; Magnetic resonance imaging; Screening; Sensitivity; Specificity

Indexed keywords

ADULT; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CANCER; BREAST CARCINOMA; BREAST DENSITY; BREAST FIBROADENOMA; BREAST PAPILLOMA; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIBROCYSTIC BREAST DISEASE; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPHOMA; MAMMOGRAPHY; MASTECTOMY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ANALOGS AND DERIVATIVES; BREAST; BREAST CYST; BREAST TUMOR; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; LARGE CORE NEEDLE BIOPSY; LUNG CARCINOMA; MASS SCREENING; MIDDLE AGED; PAGET NIPPLE DISEASE; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

CONTRAST MEDIUM; GADOBENIC ACID; GADOLINIUM PENTETATE; MEGLUMINE; ORGANOMETALLIC COMPOUND;

BIOPSY, LARGE-CORE NEEDLE; BREAST; BREAST CYST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CLINICAL PROTOCOLS; COHORT STUDIES; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84938750431     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2015.06.004     Document Type: Article

References (37)

1. Mainiero M.B., Lourenco A., Mahoney M.C., et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 2013, 10:11-14.
2. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75-89.
3. Morrow M., Waters J., Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet 2011, 378:1804-1811.
4. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
5. Pilewskie M., King T.A. Magnetic resonance imaging in patients with newly diagnosed breast cancer: a review of the literature. Cancer 2014, 120:2080-2089.
6. Hagen A.I., Kvistad K.A., Maehle L., et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 2007, 16:367-374.
7. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23:8469-8476.
8. Stout N.K., Nekhlyudov L., Li L., et al. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med 2014, 174:114-121.
9. Sickles E.A. The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 2010, 48:859-878.
10. Bevers T.B., Anderson B.O., Bonaccio E., et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009, 7:1060-1096.
11. Protocols for the surveillance of women at higher risk of developing breast cancer 2013, National Health System.
12. OBSP screening for women at high risk 2014, Accessed August 31, 2014. https://www.cancercare.on.ca/cms/one.aspx?portalId=1377&pageId=99638.
13. Harvey J.A., Bovbjerg V.E. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004, 230:29-41.
14. Sprague B.L., Gangnon R.E., Burt V., et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014, 106:1-6.
15. Ho J.M., Jafferjee N., Covarrubias G.M., et al. Dense breasts: a review of reporting legislation and available supplemental screening options. AJR Am J Roentgenol 2014, 203:449-456.
16. Freer P.E. Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics 2015, 35:302-315.
17. Berg W.A., Zhang Z., Lehrer D., et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012, 307:1394-1404.
18. Kuhl C., Weigel S., Schrading S., et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010, 28:1450-1457.
19. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292:1317-1325.
20. Riedl C.C., Luft N., Bernhart C., et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 2015, 33:1128-1135.
21. Killelea B.K., Long J.B., Chagpar A.B., et al. Evolution of breast cancer screening in the Medicare population: clinical and economic implications. J Natl Cancer Inst 2014, 106:1-8.
22. Ahern C.H., Shih Y.C., Dong W., et al. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer 2014, 111:1542-1551.
23. Feig S. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am 2010, 48:879-891.
24. Griebsch I., Brown J., Boggis C., et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer 2006, 95:801-810.
25. Moore S.G., Shenoy P.J., Fanucchi L., et al. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res 2009, 9:9.
26. Pataky R., Armstrong L., Chia S., et al. Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers. BMC Cancer 2013, 13:339.
27. Taneja C., Edelsberg J., Weycker D., et al. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 2009, 6:171-179.
28. Kuhl C.K., Schrading S., Strobel K., et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol 2014, 32:2304-2310.
29. Mann R.M., Mus R.D., van Zelst J., et al. A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging. Invest Radiol 2014, 49:579-585.
30. Trimboli R.M., Verardi N., Cartia F., et al. Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study. AJR Am J Roentgenol 2014, 203:674-681.
31. Mango V.L., Morris E.A., David Dershaw D., et al. Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection?. Eur J Radiol 2015, 84:65-70.
32. Schuirmann D.J. On hypothesis testing to determine if the mean of a normal distribution is contained in a known interval. Biometrics 1981, 37:617.
33. Berg W.A., Blume J.D., Cormack J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008, 299:2151-2163.
34. Haas B.M., Kalra V., Geisel J., et al. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013, 269:694-700.
35. Warner E., Messersmith H., Causer P., et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008, 148:671-679.
36. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351:427-437.
37. Partridge S.C., Stone K.M., Strigel R.M., et al. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions. Acad Radiol 2014, 21:1195-1203.